[
  {
    "ts": null,
    "headline": "Charles River Laboratories International Inc. stock underperforms Monday when compared to competitors",
    "summary": "Charles River Laboratories International Inc. stock underperforms Monday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=aa1c371f0d68cb4de8a66c588084257a4f528e3a0eed29f0a54cda1493fac791",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743441660,
      "headline": "Charles River Laboratories International Inc. stock underperforms Monday when compared to competitors",
      "id": 133689316,
      "image": "",
      "related": "CRL",
      "source": "MarketWatch",
      "summary": "Charles River Laboratories International Inc. stock underperforms Monday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=aa1c371f0d68cb4de8a66c588084257a4f528e3a0eed29f0a54cda1493fac791"
    }
  },
  {
    "ts": null,
    "headline": "Charles River & Valo Health's Logica Identifies New Lupus Drug Candidate",
    "summary": "Charles River and Valo Health identify a potential therapeutic for lupus using their combined offering, Logica.",
    "url": "https://finnhub.io/api/news?id=bc60f6c704bfb48648f7728911ac44c00afd76d0e11095a52ff62c9f4918908c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743427200,
      "headline": "Charles River & Valo Health's Logica Identifies New Lupus Drug Candidate",
      "id": 133627830,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "Charles River and Valo Health identify a potential therapeutic for lupus using their combined offering, Logica.",
      "url": "https://finnhub.io/api/news?id=bc60f6c704bfb48648f7728911ac44c00afd76d0e11095a52ff62c9f4918908c"
    }
  }
]